Tuesday

16th Aug 2022

'Historic day' as EU patent deal ends 40-year wait

  • Atomium - Brussels' signature monument to scientific research (Photo: O Palsson)

The 40-year-long quest to create a single European patent ended on Tuesday (11 December) when the European Parliament ratified a deal which will come into force in 2014.

Speaking in the assembly in Strasbourg, EU single market commissioner Michel Barnier said that the achievement marked a "historic day."

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

Under the regime, inventors will be able to apply to the European Patent Office for a patent valid in 25 of the bloc's 27 member states.

Spain and Italy will remain outside the scope of the patent regime in protest that patents will only be available in English, French or German-language versions.

The three legislative files on the unitary patent, language regime and unified patent court, were each backed by wide majorities with over 480 MEPs in favour.

Supporters of a unitary patent claim that it will drastically reduce costs for businesses and entrepreneurs. Europe-wide patents currently cost around €35,000 each, according to the European Patent Office (EPO), almost 10 times the cost in the US. The European Commission says that EU patent costs could fall to €4,725.

However, the Green group broke ranks in opposing the deal, describing its validity as "legally uncertain" and criticising the status of the EPO and its European Patent Court, which is to exist outside the EU treaty framework.

Christian Engstrom - the Swedish Pirate party deputy and the group's spokesman on intellectual property rights - said the proposal "hands control over European innovation policy to patent lawyers with vested interests, and not the democratically elected legislators."

MEPs had previously demanded that the Luxembourg-based European Court of Justice (ECJ), which acts as arbiter on the application of EU law, should always be the first port of call for patent disputes, but now the patent court will play that role instead.

They had also criticised moves made in July by ministers to strip Articles 6 to 8 out of the patent law, which covered the right for patent holders to prevent the use of their invention for some applications and to put other limitations on their patents.

Speaking at a press conference after the vote, German centre-left MEP, Bernhard Rapkay, admitted that the deal was "a sub-optimal solution."

He added that MEPs had come under intense pressure from lobbyists to veto the deal in the weeks leading up to the vote.

Meanwhile, parliament legal Affairs committee chair Klaus Hehne Lehne told reporters that the rules would strengthen the EU's hand when negotiating on patent rules with China.

"We have closed an important gap in the single market," added the German centre-right deputy.

For his part, Jonathan Zuck, President of the Association for Competitive Technology, said the new system would "remove a major hurdle to innovation and growth" by protecting small businesses form "fragmented national legislation."

Angry MEPs postpone patent vote

Just days after being hailed as solved, the EU decades-long quest for a single patent hit an unexpected snag on Monday evening when MEPs postponed a vote on the draft patent claiming member states had "emasculated" the proposal.

British MPs demand London court to counter EU patent costs

MPs on the UK's House of Commons European Scrutiny committee have demanded that the new EU patent court be based in London in order to mitigate against what it described as "the most damaging effects of a unitary EU-wide patent".

Opinion

Intellectual property protection - the cure for Europe's ills

The European Commission is considering rolling back medical research incentives, on the faulty assumption they are somehow driving higher drug prices. But not only is that premise flawed – the proposed fix will do nothing to benefit ordinary health consumers.

Opinion

Why are our medicines so expensive?

The EU should be promoting open innovation in upcoming trade talks with India and should work to bring down the prices of essential medicines, both abroad and within its borders.

Column

Albania's post-communist dream has lessons for Ukraine

Comparisons between post-communist Albania and current-day Ukraine are fascinating — and make many pertinent parallels. Ukrainians have a similar determination to belong to "the rest of Europe" as Albanians.

Opinion

Finally, the victims of Utøya got a memorial

A legal battle between locals on the one hand and the state and the labour youth organisation on the other side postponed the inception of the memorial in remembrance of the victims of Anders Behring Breivik.

Stakeholders' Highlights

  1. Nordic Council of MinistersNordic prime ministers: “We will deepen co-operation on defence”
  2. EFBWW – EFBH – FETBBConstruction workers can check wages and working conditions in 36 countries
  3. Nordic Council of MinistersNordic and Canadian ministers join forces to combat harmful content online
  4. European Centre for Press and Media FreedomEuropean Anti-SLAPP Conference 2022
  5. Nordic Council of MinistersNordic ministers write to EU about new food labelling
  6. Nordic Council of MinistersEmerging journalists from the Nordics and Canada report the facts of the climate crisis

Latest News

  1. Germany rejects visa ban for Russian tourists
  2. Iran responds to EU's 'final text' on nuclear deal
  3. Model minority myths
  4. EU must make public who really owns its fishing fleets
  5. Germany needs to cut gas use by 20% to stave off winter crisis
  6. Europe's wildfire destruction set to hit new record
  7. How Putin and Erdoğan are making the West irrelevant
  8. Defying Russian bombs, Ukraine football starts 2022 season

Join EUobserver

Support quality EU news

Join us